drugset / Trial / NCT00231673

A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy

NCT00231673

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the effect of topiramate on clinical and electrophysiological parameters in patients with diabetic peripheral polyneuropathy. The study will also evaluate the safety of topiramate in this patient population.

Timeline

Start
2001-07
Primary completion
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 200 mg Oral